VOCO has introduced MTA vpt, a mineral trioxide aggregate (MTA)–based pulp therapy cement formulated specifically for vital pulp therapy procedures. This third-generation MTA cement has been designed to address clinical needs related to pulp preservation, with enhancements in handling, strength, and biocompatibility.
The material is biocompatible, radiopaque, and releases calcium and hydroxide ions to support reparative dentin formation and pulp healing. Its high pH (~12) contributes to a bacteriostatic environment and promotes remineralization. According to the manufacturer, MTA vpt ensures a strong foundation above a vital pulp, with up to twice the compressive strength of earlier MTA formulations and reduced solubility in water.
A distinguishing feature of MTA vpt is its color-change property: it begins as light blue to aid visibility during placement and transitions to white during setting, remaining white long-term to minimize esthetic impact. It does not contain bismuth oxide or ferrous compounds, reducing the risk of discoloration, and is free of monomers, which addresses potential concerns regarding monomer-related cytotoxicity.
The cement can be placed and immediately covered with a flowable composite or glass ionomer, eliminating the need for extended setting time. VOCO notes that its multistage cement reaction allows immediate coverage after placement with a flowable composite or glass-ionomer, eliminating long wait times.
MTA vpt is primarily composed of tricalcium silicate and is radiopaque to 290% Al, facilitating radiographic identification. It is also hydrophilic and requires no separate dentin conditioning, which may streamline clinical application in pediatric procedures such as pulpotomy in primary teeth.
The product is currently available in a hand-mixed powder/liquid formulation, with a capsule-based delivery option expected in the near future. According to VOCO, the cement is priced for routine use in near-pulp restorative cases.
Further product details can be found at vocoamerica.com.